Results 211 to 220 of about 347,609 (391)

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis   +5 more
wiley   +1 more source

Gallstones and Biliary Tract Disease

open access: yesDeckerMed Family Medicine, 2019
Gregory G. Ginsberg   +1 more
openaire   +1 more source

The efficacy of 3D hologram support with mixed‐reality technique in pancreatobiliary endoscopy

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Abstract Background and Aims Mixed‐reality (MR) technology is an advanced holographic imaging system that uses wearable devices to display three‐dimensional (3D) images in clinical environments. In pancreatobiliary endoscopy, MR technology can facilitate 3D visualization of the bile and pancreatic ducts, enhancing spatial awareness and providing a more
Kazumasa Nagai   +9 more
wiley   +1 more source

Comparable impact of lymph node metastases in T2 gallbladder cancer on postoperative prognosis irrespective of the extent of the metastases: A retrospective analysis

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Abstract Background Lymph node metastases beyond the hepatoduodenal ligament are sometimes encountered in locally limited T2 gallbladder cancer (GBCA). However, the incidence and impact on prognosis remain unclear. Methods This was a retrospective multi‐institutional study of patients who underwent surgical resection for GBCA from 2002 to 2022.
Yoji Kishi   +12 more
wiley   +1 more source

MR and Ultrasound for Liver Fat Assessment in Children: Techniques and Supporting Evidence

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Hepatic steatosis is a common imaging finding that can be a sign of chronic liver disease, most often associated with metabolic dysfunction‐associated steatotic liver disease (MASLD). Imaging techniques for evaluating steatosis range from basic qualitative assessments to advanced and highly accurate quantitative metrics. Among these, MRI‐based
Suraj D. Serai   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy